BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 18628520)

  • 1. Steroid biomarkers and genetic studies reveal inactivating mutations in hexose-6-phosphate dehydrogenase in patients with cortisone reductase deficiency.
    Lavery GG; Walker EA; Tiganescu A; Ride JP; Shackleton CH; Tomlinson JW; Connell JM; Ray DW; Biason-Lauber A; Malunowicz EM; Arlt W; Stewart PM
    J Clin Endocrinol Metab; 2008 Oct; 93(10):3827-32. PubMed ID: 18628520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel H6PDH mutations in two girls with premature adrenarche: 'apparent' and 'true' CRD can be differentiated by urinary steroid profiling.
    Lavery GG; Idkowiak J; Sherlock M; Bujalska I; Ride JP; Saqib K; Hartmann MF; Hughes B; Wudy SA; De Schepper J; Arlt W; Krone N; Shackleton CH; Walker EA; Stewart PM
    Eur J Endocrinol; 2013 Feb; 168(2):K19-26. PubMed ID: 23132696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations in the genes encoding 11beta-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase interact to cause cortisone reductase deficiency.
    Draper N; Walker EA; Bujalska IJ; Tomlinson JW; Chalder SM; Arlt W; Lavery GG; Bedendo O; Ray DW; Laing I; Malunowicz E; White PC; Hewison M; Mason PJ; Connell JM; Shackleton CH; Stewart PM
    Nat Genet; 2003 Aug; 34(4):434-9. PubMed ID: 12858176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A study of the hexose-6-phosphate dehydrogenase gene R453Q and 11beta-hydroxysteroid dehydrogenase type 1 gene 83557insA polymorphisms in the polycystic ovary syndrome.
    San Millán JL; Botella-Carretero JI; Alvarez-Blasco F; Luque-Ramírez M; Sancho J; Moghetti P; Escobar-Morreale HF
    J Clin Endocrinol Metab; 2005 Jul; 90(7):4157-62. PubMed ID: 15827106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarkers of hypothalamic-pituitary-adrenal axis activity in mice lacking 11β-HSD1 and H6PDH.
    Abrahams L; Semjonous NM; Guest P; Zielinska A; Hughes B; Lavery GG; Stewart PM
    J Endocrinol; 2012 Sep; 214(3):367-72. PubMed ID: 22718432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genotypes at 11beta-hydroxysteroid dehydrogenase type 11B1 and hexose-6-phosphate dehydrogenase loci are not risk factors for apparent cortisone reductase deficiency in a large population-based sample.
    White PC
    J Clin Endocrinol Metab; 2005 Oct; 90(10):5880-3. PubMed ID: 16091483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cortisone-reductase deficiency associated with heterozygous mutations in 11beta-hydroxysteroid dehydrogenase type 1.
    Lawson AJ; Walker EA; Lavery GG; Bujalska IJ; Hughes B; Arlt W; Stewart PM; Ride JP
    Proc Natl Acad Sci U S A; 2011 Mar; 108(10):4111-6. PubMed ID: 21325058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 11beta-hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response.
    Tomlinson JW; Walker EA; Bujalska IJ; Draper N; Lavery GG; Cooper MS; Hewison M; Stewart PM
    Endocr Rev; 2004 Oct; 25(5):831-66. PubMed ID: 15466942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of Association of the 11beta-hydroxysteroid dehydrogenase type 1 gene 83,557insA and hexose-6-phosphate dehydrogenase gene R453Q polymorphisms with body composition, adrenal androgen production, blood pressure, glucose metabolism, and dementia.
    Smit P; Dekker MJ; de Jong FJ; van den Beld AW; Koper JW; Pols HA; Brinkmann AO; de Jong FH; Breteler MM; Lamberts SW
    J Clin Endocrinol Metab; 2007 Jan; 92(1):359-62. PubMed ID: 17062770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hexose-6-phosphate dehydrogenase and 11beta-hydroxysteroid dehydrogenase-1 tissue distribution in the rat.
    Gomez-Sanchez EP; Romero DG; de Rodriguez AF; Warden MP; Krozowski Z; Gomez-Sanchez CE
    Endocrinology; 2008 Feb; 149(2):525-33. PubMed ID: 18039793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular and genetic models of H6PDH and 11β-HSD1 function in skeletal muscle.
    Zielinska AE; Fletcher RS; Sherlock M; Doig CL; Lavery GG
    Cell Biochem Funct; 2017 Jul; 35(5):269-277. PubMed ID: 28749080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hexose-6-phosphate dehydrogenase contributes to skeletal muscle homeostasis independent of 11β-hydroxysteroid dehydrogenase type 1.
    Semjonous NM; Sherlock M; Jeyasuria P; Parker KL; Walker EA; Stewart PM; Lavery GG
    Endocrinology; 2011 Jan; 152(1):93-102. PubMed ID: 21106871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variants implicated in cortisone reductase deficiency do not contribute to susceptibility to common forms of polycystic ovary syndrome.
    Draper N; Powell BL; Franks S; Conway GS; Stewart PM; McCarthy MI
    Clin Endocrinol (Oxf); 2006 Jul; 65(1):64-70. PubMed ID: 16817821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hexose-6-phosphate dehydrogenase confers oxo-reductase activity upon 11 beta-hydroxysteroid dehydrogenase type 1.
    Bujalska IJ; Draper N; Michailidou Z; Tomlinson JW; White PC; Chapman KE; Walker EA; Stewart PM
    J Mol Endocrinol; 2005 Jun; 34(3):675-84. PubMed ID: 15956339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hexose 6-phosphate dehydrogenase (H6PD) and corticosteroid metabolism.
    White PC; Rogoff D; McMillan DR; Lavery GG
    Mol Cell Endocrinol; 2007 Feb; 265-266():89-92. PubMed ID: 17240046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hexose-6-phosphate dehydrogenase modulates 11beta-hydroxysteroid dehydrogenase type 1-dependent metabolism of 7-keto- and 7beta-hydroxy-neurosteroids.
    Nashev LG; Chandsawangbhuwana C; Balazs Z; Atanasov AG; Dick B; Frey FJ; Baker ME; Odermatt A
    PLoS One; 2007 Jun; 2(6):e561. PubMed ID: 17593962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue-specific dysregulation of hexose-6-phosphate dehydrogenase and glucose-6-phosphate transporter production in db/db mice as a model of type 2 diabetes.
    Wang Y; Nakagawa Y; Liu L; Wang W; Ren X; Anghel A; Lutfy K; Friedman TC; Liu Y
    Diabetologia; 2011 Feb; 54(2):440-50. PubMed ID: 21052977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minireview: hexose-6-phosphate dehydrogenase and redox control of 11{beta}-hydroxysteroid dehydrogenase type 1 activity.
    Hewitt KN; Walker EA; Stewart PM
    Endocrinology; 2005 Jun; 146(6):2539-43. PubMed ID: 15774558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A follow-up history of young man with apparent cortisone reductase deficiency (ACRD) - several years after diagnosis.
    Zajkowska A; Rydzewska M; Wojtkielewicz K; Pomaski J; Romer T; Bossowski A
    Pediatr Endocrinol Diabetes Metab; 2017; 23(1):42-48. PubMed ID: 29073307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations of Cortisol Metabolism in Human Disorders.
    White PC
    Horm Res Paediatr; 2018; 89(5):320-330. PubMed ID: 29843121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.